Institute for International Research

Dear Industry Colleague,

Does the reimbursement process leave you frustrated?
Have you ever wanted coverage answers you couldn't get?
Have you ever wished you could untangle the complicated coding process?

If you answered yes to one of the questions above, this is the MUST attend event for you and your team.

FDA Approval is No Longer Sufficient
In recent years, the industry has learned that FDA approval is no longer sufficient for securing reimbursement. This change in policy has significantly impacted the way you do business, bringing evidence based medicine to the forefront of your reimbursement plan. Without knowledge of the latest requirements and procedures, you risk product failure.

Our Promise
The Institute for International Research is proud to present the Strategic Planning for Medical Device Reimbursement conference. This event promises to deliver the latest developments through a dynamic program run by industry leaders. We highlight the most pressing issues in coding, coverage, and payment. In addition, you will learn directly from the industry's key decision makers about the most recent developments.

Act Now
The time is now to learn the latest practices in reimbursement. Don't miss your chance to network with top industry professionals, CMS representatives, and health plans. Get the answers to your most burning questions, learn successful strategies, and gain the necessary knowledge you need to navigate the complex reimbursement process.

Register today! We look forward to seeing you in Baltimore on July 30th!

Sincerely,

Jennie Friedlich
Event Director, Health Care Division
Institute for International Research

Valerie Bowling
General Manager, Health Care Division
Institute for International Research